FindHealthNews Index  |  Save/Exchange Information |  WikiWax

    News, Reviews, and Articles on Placebo

    Archives: Placebo

    Click to read:Tamiflu-Resistant H1N1 Cluster Reported  Nov 21, 2009
    Tamiflu-Resistant H1N1 Cluster Reported - CBS News. ATLANTA, Nov. 20, 2009. (CBS News)

    New Drug May Be Female Viagra  Nov 21, 2009
    Testing Flibanserin At the Congress, researchers reported the pooled results for 1,378 pre-menopausal women, with an average age of 35, who took 100 milligrams of the drug or a placebo pill during a 24-week period ... Those on placebo went from 2 ... About 15 percent of the women taking the medication dropped out due to adverse events, according to information from Boehringer Ingelheim Pharmaceuticals, which makes the medications, while 7 percent of women on placebo discontinued the study. (CBS News -- Health)

    Shionogi's Sex-Extending Spray May Help Premature Ejaculators, Study Finds  Nov 21, 2009
    8 minute for those given a placebo, according to the results of the study presented yesterday at the annual meeting of the. Sciele said in May it would prepare to submit the treatment for regulatory review in the first half of 2010. (Bloomberg -- Asia)

    Abbott's diet drug's risks have FDA's attention  Nov 21, 2009
    The FDA said early findings from a recent study suggested patients taking Meridia, also known as sibutramine, may have a higher number of cardiovascular-related problems, including heart attacks, strokes, cardiac arrests and deaths, when compared to patients who took a placebo. A spokesman for Abbott said the study, launched in 2003 at the request of European regulators, involved high-risk patients with a history of cardiovascular problems. (Crain's Chicago Business)

    Richard Hinds John Coates is the Captain Mainwaring of Australian sport. Read more  Nov 21, 2009
    As a petulant personal assault on Crawford's ''well-meaning'' panel revealed, Dad's Army is bereft of hard evidence to back its vague claims that Olympic glory treats what ails Australian society with anything more than a four-yearly placebo. Without ammunition, they attack with sticks and stones. (The Age, Australia)

    Newer Blood Thinners May Outperform Old Standbys  Nov 20, 2009
    The trial involved more than 1,800 patients in 24 countries with acute coronary syndrome who were randomized to receive one of four doses of dabigatran, made by Boehringer Ingelheim, or a placebo ... In one of the two latest trials, both conducted by researchers at Sinai Hospital in Baltimore, patients with stable coronary artery disease who were also taking aspirin were randomized to Brilinta, Plavix or a placebo for six weeks. (MEDLINEplus)

    STEM CELLS: THE FIRST HUMAN TRIAL...  Nov 20, 2009
    REPAIR STEM CELL PLACEBO EFFECT. 10 REAL OPTIC NERVE HYPOPLASIA VICTORIES. (The Drudge Report)

    'Female Viagra'?  Nov 20, 2009
    While significant differences were found between those taking the drug versus those using the placebo in North America, the European trials found no significant increase in sexual satisfying events between its two comparison groups. Answering this question stands to open a whole can of worms, including how an individual measures desire. (Fox News)

    Soon, a spray to prevent premature ejaculation  Nov 20, 2009
    The study showed that men treated with PSD502 were able to delay ejaculation up to five times longer than those who used placebo. It works selectively on non-keratinized skin on the glans penis (head of the penis). (India Times, India)

    HIV Vaccine Failure Probably Caused by Virus Used, Says New Research  Nov 20, 2009
    The trial, called 'STEP', was halted in September 2007 because preliminary results suggested that people who had been given the vaccine were more likely to be infected with HIV than people who had been given a placebo ... Preliminary results of the vaccine trial showed that people who had previously been infected with the adenovirus used in the trial had a significantly higher risk of being infected with HIV following the vaccine compared to people who were given a placebo. (Science Daily)

    Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy  Nov 20, 2009
    Study Identifies Optimal Treatment Approach for Late-Stage Development. As well as benefiting patients, this effect scientifically validates the ToleroMune approach and its novel focus on generating regulatory T cells to shut down this type of IgE-mediated allergic response. (Canada Newswire)

    Viagra Helpful for Children with Heart Defect  Nov 19, 2009
    The patients, average age 15, were given either a placebo or 20 milligrams of sildenafil three times daily for six weeks. That was followed by six weeks of no drug or placebo, and then the participants were switched to the opposite arm of the study for another six weeks ... Before and after each phase of the study, researchers assessed the participants' heart function and found significant improvements in the myocardial performance index during the sildenafil phase compared to the placebo phase.... (MEDLINEplus)

    Your Own Stem Cells Can Treat Heart Disease, Study Suggests  Nov 19, 2009
    Twelve months after the procedure, the transplant subjects were able to double their improvement on a treadmill compared to the placebo group. It also took twice as long until they experienced angina pain on a treadmill compared to the placebo group, and, when they felt pain, it went away faster with rest. (Science Daily)

    Treatment With Folic Acid, Vitamin B12 Associated With Increased Risk of Cancer, Death  Nov 19, 2009
    The two randomized, placebo-controlled clinical trials included 6,837 patients with ischemic heart disease who were treated with B vitamins or placebo between 1998 and 2005, and were followed up through December 31, 2007 ... 4 mg/d) (n = 1,703); vitamin B6 alone (40 mg/d) (n = 1,705); or placebo (n = 1,721) ... 12, 2005) Patients who took folic acid and vitamin B12 after their stroke had a reduced risk of hip fracture compared to patients who took placebo, according to an article in the March 2... (Science Daily)

    Genzyme gives up on phosphate drug  Nov 19, 2009
    The new product was better than a placebo, meeting the primary goal of a 349-person trial in the final stages of testing that s usually required for US approval. The drug was designed to be a more potent version of Renvela, approved in 2007 to control phosphorus levels in patients with chronic kidney disease. (Boston Globe)

    A Trial of Darbepoetin Alfa to Reduce Cardiovascular Events  Nov 19, 2009
    Methods In this study involving 4038 patients with diabetes, chronic kidney disease, and anemia, we randomly assigned 2012 patients to darbepoetin alfa to achieve a hemoglobin level of approximately 13 g per deciliter and 2026 patients to placebo, with rescue darbepoetin alfa when the hemoglobin level was less than 9 ... Results Death or a cardiovascular event occurred in 632 patients assigned to darbepoetin alfa and 602 patients assigned to placebo (hazard ratio for darbepoetin alfa vs.... (New England Journal of Medicine)

    Alpha1-Antitrypsin Deficiency  Nov 19, 2009
    To the Editor: In their Clinical Practice article (June 25 issue),1 Silverman and Sandhaus mention two small trials of augmentation therapy for alpha1-antitrypsin (AAT) deficiency that have been performed2,3 and note that there were "marginally significant reductions in the progression of emphysema, as assessed on quantitative CT [computed tomography] densitometry," but "no significant slowing in the decline in FEV1 [forced expiratory volume in 1 second]." However, FEV1 is the accepted method,... (New England Journal of Medicine)

    Drug for Erectile Dysfunction Improves Heart Function in Young Heart-Disease Patients  Nov 19, 2009
    In this study, researchers randomized 28 children and young adults who had undergone the Fontan operation to receive placebo or sildenafil three times a day for 6 weeks. After a 6-week break, subjects were switched to the opposite treatment course. (Science Daily)

    Failed anti-depressant drug could be 'women's Viagra'...  Nov 18, 2009
    Nearly 2,000 pre-menopausal women were given flibanserin or a placebo for 24 weeks and asked to report back to researchers or make diary entries on six variables, including the number of satisfactory sexual encounters they had and their level of sexual desire. The studies found that 100 milligrams a day of flibanserin resulted in "significant improvements" in the two variables. (The Drudge Report)

    Female Sexual Dysfunction: Myth or Malady?  Nov 18, 2009
    The women were randomly assigned to take 100 mg of flibanserin or a placebo daily and to record daily whether they had sex and whether it was satisfying ... Women in the placebo group reported an increase from 2 ... The difference in effect between flibanserin and the placebo about 0. (Time.com)

    Now, a Viagra for women?  Nov 18, 2009
    A total of 1,946 pre-menopausal women aged 18 and older were randomised to receive either flibanserin or placebo for 24 weeks, with four weeks of pre-treatment and four weeks of post-treatment follow-up. These results were presented Monday at the Congress of the European Society for Sexual Medicine in Lyon, France. (India Times, India)

    Folic Acid Fortification Might Boost Cancer Risk  Nov 18, 2009
    In the studies, patients were randomly assigned to receive folic acid plus vitamins B12 and B6, folic acid plus B12, or B6 alone, or a placebo. These trials ran from 1998 to 2005, and were followed through the end of 2007. (Atlanta Journal-Constitution -- Health)

    Alkermes higher on Vivitrol optimism  Nov 17, 2009
    Subjects injected with Vivitrol once per month were more likely to pass a urine test than patients who received a placebo, Alkermes said. The drug also met secondary goals; subjects reported a lower craving for drugs, and half were clean in at least 90 percent of their drug tests. (Boston Globe)

    Viagra for Women? Drug Developed as Antidepressant Effective in Treating Low Libido  Nov 17, 2009
    Drug developed as antidepressant effective in treating low libido. Drug Developed as Antidepressant Effective in Treating Low Libido. (Science Daily)

    Renewed Hope for an AIDS Vaccine  Nov 17, 2009
    Specifically, 74 people who had received the placebo became infected with HIV in the trial period, compared with the 51 people who became infected after receiving the vaccine, which makes for a protective effect of 31 ... By including, however, the seven people who turned out to have had HIV at the start of the trial (two in the placebo group and five in the vaccine group), the effectiveness drops to 26. (Scientific American)

    A Viagra For Women? New Drug Shows Promise  Nov 17, 2009
    The Phase III placebo-controlled studies on flibanserin also raise questions about whether HSDD is a legitimate medical condition or another pharmaceutical company invention to sell drugs ... There was also a very strong placebo effect among the women. (ABC News)

    Laser Therapy Helps Neck Pain  Nov 17, 2009
    In five trials, patients given LLLT were around four times likelier to have reduced pain compared with a placebo, the paper found. In the 11 other trials, for which there was a detailed analysis of pain symptoms, LLLT patients reported reductions of chronic pain by around 20 points on a scale of 100 points. (Newsmax)

    New Drug Appears to Fire Up Female Sex Drive  Nov 17, 2009
    In the control group on placebo the rate rose to 3 ... Women on the drug also reported a higher level of sexual desire and less distress from sexual dysfunction than those on placebo ... This prompted about one in seven participants on flibanserin to drop out of the therapy, while the drop-out rate was roughly one in 14 in the placebo group, the data show. (Fox News)

    Abbott's Niaspan Works Better Than Merck's Zetia in Artery Clearing Study  Nov 16, 2009
    Data presented in July 2008, in a trial called SEAS, found more patients taking Vytorin developed cancer than those on a placebo, a finding later contradicted in another study. Merck Study. (Bloomberg -- US)

    Study says drug does little, proving need for more testing  Nov 16, 2009
    Aranesp did no better than a placebo in preventing heart disease, reduced fatigue only modestly, and nearly doubled a patient s risk of a stroke ... Until now, no researchers had measured Aranesp against a placebo for such patients ... Pfeffer s study showed not only that the drug did not prevent heart attacks or deaths, but those taking it suffered 101 fatal or nonfatal strokes, compared with 53 taking the placebo. (Boston Globe)

    Quitters get a shot in the arm with smoking vaccine  Nov 16, 2009
    In early October in the Archives of General Psychiatry, scientists reported the results of a cocaine vaccine study, the first successful placebo-controlled trial of a vaccine against an illicit drug of abuse ... As in most clinical trials, Ballou was not told whether he was getting the real thing or a placebo ... But, he says, after the first shot, "I knew instantly that I was not getting the placebo. I was overjoyed." How could he tell. (USA Today)

    Honey May be Best Cough Medicine  Nov 15, 2009
    This study s results showed that DM was no more effective than the placebo (no treatment) at treating cough. Some subjects in the placebo group and the DM group reported an improvement in symptoms, and this might be due to the natural course of an upper respiratory infection. (Suite101.com)

    Seizure Drug Helps Women with Hot Flashes Sleep  Nov 15, 2009
    The subjects took either 300 milligrams of gabapentin three times a day or a placebo. Based on the Pittsburgh Sleep Quality Index -- a well-known and validated sleep questionnaire, they found that women who took gabapentin reported better quality sleep than those who took placebo. (MEDLINEplus)

    Dopamine Enhances Expectation of Pleasure  Nov 15, 2009
    They were then given L-DOPA or a placebo and asked to imagine holidaying in those destinations. The following day participants had to pick between a series of paired destinations that they had initially assigned with equal ratings, one member of the pair was imagined under L-DOPA the day before and the other under placebo. (Science Daily)

    Laser Therapy Seems to Relieve Neck Pain  Nov 14, 2009
    Those who received low-level laser therapy, in which a beam of focused radiation in the infrared to visual light portion of the spectrum is aimed at the painful area of the neck, were 70 percent more likely to report reduced pain than those given placebo treatment with a beam of ordinary light, the report said. Five trials with people suffering chronic, persistent neck pain found that those who got laser treatment were four times more likely to have reduced pain compared with placebo ... "Such a... (MEDLINEplus)

    Lexicon shares climb on trial results  Nov 14, 2009
    Lexicon (NASDAQ: LXRX) said patients who took one gram of LX1031 four times daily during the four-week study had less pain and discomfort than patients who took a placebo. Lexicon shares ended Friday's session up 13 cents, about 9 percent, to close at $1. (Houston Business Journal, TX)

    Experts: Placebo effect behind many 'natural' cures  Nov 14, 2009
    The placebo effect is the ability of a dummy pill or a faked treatment to make people feel better, just because they expect that it will ... It's the placebo effect the ability of a dummy pill or a faked treatment to make people feel better, just because they expect that it will ... In just the past few weeks, the placebo effect has demonstrated its healing powers. (USA Today -- News)

    Lexicon says IBS drug met mid-stage study goal  Nov 14, 2009
    The company said patients who took 1,000 milligrams of LX1031 four times per day had significantly less pain and discomfort from irritable bowel syndrome, or IBS, compared to patients who took a placebo ... The company said side effects were similar for patients who took LX1031 and patients who took a placebo. (Yahoo News -- Pharmaceutical Industry News)

    Less HRT, Fewer Cases of Possible Breast Cancer Precursor  Nov 14, 2009
    The Women's Health Initiative was halted in July of 2002 after researchers found higher risks of heart attacks and breast cancer in women taking the hormone supplements compared with placebo. Since that time, use of hormone replacement therapy (HRT) has experienced a precipitous decline. (MEDLINEplus)

    Fish Oil Supplements Don't Help Depressed Heart Patients  Nov 14, 2009
    For this study, 122 patients with major depression and coronary heart disease took 50 milligrams of Zoloft a day, then were randomized to receive either 2 grams a day of omega-3 acid ethyl esters or a corn-oil placebo capsule ... "It's definitely better than placebo, better than doing nothing. We're trying to find a treatment or combination of treatments that's going to significantly improve the depression outcome." ... GlaxoSmithKline Inc. provided both omega-3 and placebo capsules, while... (MEDLINEplus)

    SURVEY: Half of doctors prescribe placebos  Nov 14, 2009
    Half of doctors prescribe placebos, survey shows - USATODAY.com ... Half of doctors prescribe placebos, survey shows ... In a National Institutes of Health survey, 62% of doctors said they believe using a placebo treatment is ethically acceptable. (USA Today -- News)

    It's official: Love also breeds jealousy  Nov 13, 2009
    The present study comprised 56 volunteers, half of whom inhaled the synthetic form of the hormone in the first session and were then given a placebo (a dummy drug) in the second session. Others were given a placebo first and Oxytocin later. (India Times, India)

    How to stay healthy during flu season  Nov 13, 2009
    Yogurt: Shift workers who consumed a drink containing Lactobacillus reuteri, a probiotic that appears to stimulate infection-fighting white blood cells, were 33 percent less likely to take sick days than those who took a placebo, according to an 80-day Swedish study published in Environmental Health. But beware, says Elizabeth Somer, RD, author of 10 books on nutrition: "Some companies make up probiotic names to put on their label." She suggests looking for yogurt that contains Lactobacillus... (MSNBC -- Health)

    Female Desire Drug Sparking Libido May Prove Sex Really Is All in Her Head  Nov 13, 2009
    Berner said his patients were largely professionals in their early 30s to mid-40s, and most chose to continue in the trial in a subsequent phase that ensured they would get the real drug instead of a placebo. Boehringer is recruiting older women for a follow-up study. (Bloomberg -- Europe)

    Drug Ads Can Hurt Health, Study Says  Nov 13, 2009
    He also called for precise information about the possible benefits and how it compares to a placebo or other treatments. The same goes for the risks. (KIRO TV, WA)

    How to Save Billions On Health Care Now  Nov 13, 2009
    Aside from data showing that elective angioplasties don't save lives, a recent study found that vertebroplasty, a common procedure to treat pain from back fractures, was than a placebo treatment with a shot to temporarily numb the area. Ultimately, insurers will try to change behavior by refusing to cover services that have performed poorly in comparative effectiveness research. (CBS News)

    New Diet Pills Show Promise for Weight Loss  Nov 13, 2009
    "I really thought I was on the placebo for a long time because I didn't have any side effects," Evans said. "I did finally realize that I didn't have any hunger pains.". (ABC News)

    Despite some benefit, drug ads can be harmful to your health  Nov 12, 2009
    The ads should state how this drug compared to placebo or other available treatments, including generic drugs. Ads should provide specific quantitative information about the potential risks associated with drugs without other visual or audio distractions, so consumers can better understand the risks associated with the prescription drugs. (EurekAlert!)

    Nerve myelination and ascorbic acid  Nov 12, 2009
    Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial ... Patients below age 25 years were randomly assigned to receive placebo or ascorbic acid (one gram twice daily) in a double-blind fashion during one year ... There were no significant differences between the six placebo-treated (median age 16 years, range 13 to 24) and the five ascorbic acid-treated (19, 14 to 24) patients in change in motor nerve... (BioMed Central)

    Belief Powers Natural Meds, Experts Say  Nov 12, 2009
    Placebo Effect Not Necessarily Bad, Some Say ... It's the placebo effect -- the ability of a dummy pill or a faked treatment to make people feel better, just because they expect that it will ... In just the past few weeks, the placebo effect has demonstrated its healing powers. (KIRO TV, WA)

    Kids popping pills that can kill  Nov 12, 2009
    Experts: Placebo power behind many natural cures. EDITOR'S NOTE: Ten years and $2. (Fresno Bee -- Lifestyle)

    Low cholesterol may prevent some prostate cancers  Nov 12, 2009
    She led the first study, which looked at 5,586 men aged 55 and older who were in the placebo group of a big federal cancer prevention study done in the 1990s. Cholesterol levels made no difference in the odds of getting prostate cancer except for the 60 men who developed high-grade tumors, the type that grow and spread fast. (Chippewa Falls Chippewa Herald, WI)

    Diamyd's European Phase III Study Fully Recruited  Nov 12, 2009
    320 children and adolescents between 10 and 20 years of age and recently diagnosed with type 1 diabetes have now been identified and included in the company's European Phase III study and have received their first injection of the Diamyd(R) vaccine or placebo. The study is thus fully recruited. (Primezone Releases)

    Some Malignant Tumors Can Be Shut Down After All  Nov 11, 2009
    Once the tumors formed, a "mouse clinic" was set up: half of the "patients" were treated with doxycycline to induce TAp63 production, whereas the other half received a placebo. Tumor growth continued in the placebo group, with the tumors becoming five times larger within a week. (Science Daily)

    Diabetes Drug May Boost Weight Loss in Obese Patients  Nov 11, 2009
    4 milligrams or 3 milligrams) or a placebo once a day, or 120 milligrams of orlistat three times a day ... 8 kilograms (6 pounds)with placebo ... Weight loss of more than 5 percent occurred in 76 percent of patients taking 3 milligrams of liraglutide, 44 percent of patients taking orlistat, and 30 percent of patients in the placebo group, the researchers found. (MEDLINEplus)

    Low Dose Naltrexone (LDN) For Fibro...  Nov 10, 2009
    Interestingly, it was actually better tolerated than placebo. The researchers have announced a upcoming clinical trial of LDN in children with fibromyalgia (juvenile fibromyalgia). (Suite101.com)

    Drug may help smokers kick butts  Nov 10, 2009
    In the Phase II trials, Nabi reported that 30 percent to 35 percent of those given NicVAX were able to remain smoke-free over the long term, compared with only 10 percent of those receiving the placebo. "In addition, those participants that continued to smoke but showed a high antibody response to NicVAX significantly reduced the number of cigarettes smoked over the full 12-month period from a baseline of 20 cigarettes per day to 10 cigarettes per day," Nabi reported. (CNN)

    Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies  Nov 10, 2009
    The efficacy of INTUNIV in the treatment of ADHD was established in two, similarly designed, placebo-controlled clinical trials in children and adolescents aged 6 to 17 years who met Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria for ADHD. Statistically significant improvements were reported by investigators, parents, and teachers. The first pivotal trial was a phase III, double-blind, parallel-group trial, in which investigators randomized 345 children aged 6 to 17... (EurekAlert! -- Business News)

    Raising 'Good' Cholesterol Levels May Benefit Clogged Arteries  Nov 9, 2009
    71 patients, all with existing vascular disease, low levels of good cholesterol, and taking statins as prescribed by their GPs, were randomised to receive either 2 g of nicotinic acid or placebo for 1 year ... After a year, the size of the carotid artery walls in patients who had received nicotinic acid was reduced compared with placebo ... 1 sq mm, while those receiving a placebo saw an average increase in the carotid artery wall of 1. (Science Daily)

    New hope for osteoporosis sufferers (6)  Nov 9, 2009
    It also reported that there were no significant differences in the number of serious side effects between the supplement and placebo. In addition, strontium ranelate has been approved for the treatment of osteoporosis in the United Kingdom under the name Protelos. (Park Hills Daily Journal, MO)

    Making medical decisions  Nov 9, 2009
    This is also known as the placebo or nocebo effect ... Randomised controlled trials involve patients being randomly given the treatment being tested or a placebo. (The Star Online, Malaysia)

    Pfizer Broke Law by Promoting Drugs for Wrong Uses In Violation of Pledge  Nov 9, 2009
    In five company-sponsored clinical trials, 31 people out of 1,184 participants died after taking the drug for dementia -- twice the death rate for those taking a placebo ... Schering-Plough representatives said Temodar compared favorably to a placebo in clinical trials for the off-label uses and was approved by the FDA for first-line use in treating brain tumors. (Bloomberg)

    Cause Of Common Chronic Diarrhea Revealed In New Research  Nov 7, 2009
    6, 2009) A common type of chronic diarrhea may be caused by a hormone deficiency, according to new research published in the November issue of Clinical Gastroenterology and Hepatology. The authors of the paper, from Imperial College London, with collaborators from King's College London and the University of Edinburgh, say their results could help more doctors recognise this type of diarrheal illness, and may lead to the development of more effective tests and treatments to help improve the lives... (Science Daily)

    Green tea helps fight oral cancer  Nov 6, 2009
    During the study, 41oral leukoplakia patients were randomized to receive either green tea extract or placebo ... 2 percent in the placebo arm. (India Times, India)

    Some vitamins may be harmful  Nov 6, 2009
    Indeed, an editorial in the March 18, 2009, Journal of the National Cancer Institute said, "The prospects for cancer prevention through micronutrient supplementation have never looked worse. Several large, randomized cancer prevention trials have recently reported no reduced risk from micronutrient supplementation, and the short report by Figueiredo et al. in this issue of the Journal adds to a growing body of evidence that micronutrient supplementation may be harmful." Jane Figueiredo of... (Honolulu Advertiser)

    Green Tea May Help Prevent Oral Cancer  Nov 6, 2009
    Other participants took a placebo. The study found that about 59 percent of people taking the highest dose of the green tea extract showed a clinical response, compared with 18 percent of those who took a placebo. (Atlanta Journal-Constitution -- Health)

    Obesity Can Further Complicate H1N1  Nov 6, 2009
    The results of a recent study on vitamin D show that those taking 800 IU of D3 per day had far fewer colds and flu than those taking a placebo while those taking 2000 IU of D3 per day had zero incidence of colds and flu in winter, spring and autumn and the same incidence as the 800 IU group in summer with both vitamin D groups having a lower incidence than the placebo group. In the winter those taking a placebo had about 12 times as much flu as those taking 800 IUs of D3 and 23 times more than... (CBS News -- Health)

    Postmenopausal Women With Higher Testosterone May Have Greater Heart Disease Risk  Nov 6, 2009
    (May 2, 2007) Increasing the testosterone levels of female cancer survivors using testosterone cream did not improve their libido more than a placebo, according to a randomized controlled clinical trial in the. (July 30, 2008) As testosterone progressively dominates the hormonal milieu during the menopausal transition, the prevalence of metabolic syndrome increases according to a new study by researchers at Rush University. (Science Daily)

    Green tea shows promise as chemoprevention agent for oral cancer, M. D. Anderson study finds  Nov 5, 2009
    In the Phase II dose-finding study, 41 M. D. Anderson oral leukoplakia patients were randomized between August 2002 and March 2008 to receive either green tea extract or placebo ... 2 percent in the placebo arm. (EurekAlert!)

    Does green tea prevent cancer? Evidence continues to brew, but questions remain  Nov 5, 2009
    2 percent among those taking placebo. They also observed a trend toward improved histology, and a trend towards improvement in a handful of biomarkers that may be important in predicting cancer development. (EurekAlert!)

    Estrogen And Stroke Risk: Long Period Of Estrogen Deprivation Can Lead To Loss Of Sensitivity And Protective Effects In The Brain  Nov 5, 2009
    Rats whose ovaries had been removed were used for the study and received either placebo or 17 -estradiol after the ovaries were removed in an attempt to mimic the progression of estrogen loss during menopause ... Group 2 was induced with stroke and immediately received a faux drug (placebo) ... Group 4 rats received either estrogen or placebo ten weeks after being ovariectomized and one week later stroke was induced. (Science Daily)

    Coffee And Nighttime Jobs Don't Mix, Study Finds  Nov 5, 2009
    Both participant groups had to take a pill three hours before sleeping; either 200 milligrams of caffeine or a lactose-based placebo. All subjects who consumed caffeine pills had their sleep affected, especially older participants who slept 50 percent less than usual. (Science Daily)

    Early Results Of Nitric Oxide Therapy For Preemies Not Sustained, Study Finds  Nov 5, 2009
    Babies received five parts per million of iNO or a placebo within the first two days of birth and continuing for 21 days (or until the patient was taken off a ventilator). Of the 590 babies with complete survival data, 77 percent survived to one year of age (79 percent of those receiving iNO and 75 percent of those receiving placebo) ... In all, nearly 45 percent of patients from the study had died, were on oxygen, or had neurologic impairment, and there were no significant differences between... (Science Daily)

    Treating Depression in Teens Has Lasting Benefits  Nov 5, 2009
    TADS is a randomized, controlled trial evaluating the effectiveness of three common treatments for adolescents with depression: the antidepressant Prozac (also called fluoxetine); "talk therapy," also called cognitive-behavior therapy (CBT); their combination (Prozac plus CBT), and, where appropriate, management with a placebo pill (used as a control condition). A total of 327 depressed teens who participated in the study received active treatment for 36 weeks and were then followed for 1 year. (MEDLINEplus)

    Injectable Vaccines More Effective for Adult Flu Than Nasal Sprays  Nov 5, 2009
    Researchers gave 1,952 adults aged 18 to 49 either an injected flu vaccine, a placebo injection, a flu vaccine nasal spray or a placebo nasal spray during the 2007-2008 flu season ... Among those who got sick, participants who'd received the injected flu vaccine were 68 percent less likely to have the flu compared to those who'd received a placebo, according to the study ... Participants who'd received the nasal spray vaccine were 36 percent less likely to get the flu than those who'd received a... (MEDLINEplus)

    Nicotine Patch Plus Lozenge Most Effective  Nov 4, 2009
    Participants were randomly assigned to one of six treatment groups: nicotine lozenge alone, nicotine patch alone, bupropion alone, patch plus nicotine lozenge, bupropion plus nicotine lozenge or placebo ... When all the treatments were compared at the six-month point, only the individuals in the patch plus nicotine lozenge group were more successful in quitting than those taking placebo ... The lozenge, though effective with the patch, did not appear to work any better than placebo when used... (Newsmax)

    Osiris banks $15M milestone payment  Nov 4, 2009
    The latest was in September when preliminary results for two phase III trials evaluating Prochymal for the treatment of acute graft versus host disease showed no statistical difference between the drug and a placebo in either trial ... In March, the company halted enrollment in a final stage trial of Prochymal as a treatment for Crohn s disease after noting significantly higher than expected placebo response rates. (Baltimore Business Journal, MD)

    MediciNova Announces Initiation of a Phase Ib Clinical Trial for MN-221 in Patients With Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease  Nov 4, 2009
    This randomized, placebo-controlled, dose escalation Phase Ib clinical trial designed to evaluate the safety of MN-221 for the treatment of COPD exacerbations will involve approximately 48 stable, moderate to severe COPD patients. Each patient will receive a one-hour intravenous infusion of MN-221 at one of three escalating dose levels or placebo ... 0001), compared to placebo in stable mild-to-moderate asthma patients (MN-221-CL-004). (Primezone Releases)

    Human Genome reports positive data on lupus drug  Nov 4, 2009
    The anticipated study data, from a clinical program called Bliss-76, showed a 10-milligram dose of Benlysta, plus therapy with steroids, prompted an improvement in 43 percent of patients, compared with an improvement in only 33 percent of patients on the placebo end of the study. The Bliss-76 results confirm our view that Benlysta has the potential to become the first new approved drug in decades for people living with systemic lupus,'' said Human Genome President and CEO H. Thomas Watkins, in a... (India Times, India)

    Nicotine Patch Plus Lozenge Best for Quitting Smoking  Nov 4, 2009
    In fact, coupling the patch with the lozenge was the only intervention that performed better than a placebo, reported the study, which appears in the November issue of the Archives of General Psychiatry ... "As each medication comes out, it is tested against a placebo," but not against other methods, Piper explained ... For this study, 1,504 adults who had smoked at least half a pack a day for the past six months and wanted to quit were randomly assigned to a placebo or one of five different... (MEDLINEplus)

    Live healthy, avoid diabetes for a decade  Nov 3, 2009
    After three years, the results showed that rigorous lifestyle changes reduced the rate for developing type 2 diabetes by 58 percent compared with placebo, while oral diabetes drug metformin reduced the rate of developing diabetes by 31 percent compared with placebo. Over the period of 10 years, the diabetes incidence in the lifestyle group was reduced by 34 percent. (India Times, India)

    Lupus drug passes important second test  Nov 3, 2009
    8 percent of those taking a placebo in addition to standard care. Most of the patients were not able to reduce their steroid use, but that is not likely to prevent approval of the drug. (Honolulu Advertiser)

    Can testosterone therapy aid older men?  Nov 3, 2009
    It will recruit 800 men over age 65 who have especially low levels of testosterone, and will give half of them testosterone gel treatments, and other half a placebo ointment. The men will be tracked for two years to see if the group getting testosterone has significant improvement in vitality and well-being, said Dr. Peter Snyder, principal investigator and an endocrinology researcher at Penn. (Pittsburgh Post-Gazette, PA)

    Anemia Drug May Raise Stroke Risk in Kidney Patients  Nov 3, 2009
    For the study, Pfeffer's team randomly assigned more than 4,000 patients with diabetes, chronic kidney disease and anemia to receive Aranesp or placebo. During the study, 632 patients receiving Aranesp died or suffered a cardiovascular event, compared to 602 of the patients receiving placebo ... As well, 101 patients taking Aranesp had a fatal or non-fatal stroke compared with 53 of the placebo patients, the researchers found. (MEDLINEplus)

    Smokers May Need Multiple Cessation Products  Nov 3, 2009
    In the study, more than 1,500 heavy smokers who were motivated to quit were randomly assigned to 12 weeks of treatment with one or a combination of the following: nicotine patch, nicotine lozenge, bupropion-an antidepressant that reduces nicotine withdrawal symptoms, or a placebo ... Researchers found that pairing nicotine lozenges with the nicotine patch was the only treatment they tested which worked better than a placebo at six months. (KERO 23, CA)

    Archives: Placebo

    Back to FindHealthNews Home

[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2006